Some studies have evaluated AOD 9604 in combination with other compounds, such as hyaluronic acid, to assess interactions between structural support systems and peptide-mediated signaling
In addition to having a 20% lower risk overall of major cardiac events, such as heart attack, stroke, or cardiovascular death, participants who took Wegovy had a 28% reduction in heart attacks (for those already taking heart medications, such as statins, to reduce cholesterol), a 7% decrease in non-fatal strokes, and a 15% drop in cardiovascular-related deaths
Patients experiencing erectile dysfunction whilst taking tirzepatide should feel empowered to discuss these concerns with their healthcare team
These numbers move in the same direction
Heres research from GoodRx estimating coverage rates for tirzepatide and semaglutide